Voloridge Investment Management
KURA icon

Voloridge Investment Management’s Kura Oncology KURA Stock Holding History

Voloridge Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-241,095
Closed -$2.5M – 1149
2025
Q4 		$2.5M Buy
+241,095
New +$2.53M 0.01% 885
2022
Q3 		– Sell
-148,340
Closed -$2.72M – 1516
2022
Q2 		$2.72M Buy
148,340
+42,970
+41% +$618K 0.01% 915
2022
Q1 		$1.69M Buy
105,370
+91,052
+636% +$1.31M 0.01% 998
2021
Q4 		$200K Buy
14,318
+539
+4% +$8.73K ﹤0.01% 1519
2021
Q3 		$258K Sell
13,779
-813
-6% -$15.3K ﹤0.01% 1553
2021
Q2 		$304K Buy
+14,592
New +$362K ﹤0.01% 1518
2021
Q1 		– Sell
-61,236
Closed -$2M – 1538
2020
Q4 		$2M Sell
61,236
-61,052
-50% -$2.15M 0.02% 737
2020
Q3 		$3.75M Buy
+122,288
New +$2.7M 0.03% 529

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's KURA Position: Q1 2026 in Review

Voloridge Investment Management sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 241,095 shares — an estimated $2.5M sold.

Voloridge Investment Management first reported a position in KURA in Q3 2020 and held it in 8 quarters. The position peaked at $3.75M in Q3 2020. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Voloridge Investment Management reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 241,095 Kura Oncology shares in Q1 2026, an estimated $2.5M.
  • Voloridge Investment Management first reported a position in Kura Oncology in Q3 2020 and held it in 8 quarters.
  • Voloridge Investment Management's Kura Oncology position peaked at $3.75M in Q3 2020.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.